Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Despite barriers, GLP-1 coverage seen as an attractive and desired benefit Most HR decision-makers are open to adding GLP-1 medications to their benefits package 81% feel their employees are interested
AbbVie played these games with Humira, receiving 20 years of exclusivity through these same tactics
It requires: verifying the chemical compatibility between the peptides (cross-stability), optimizing the ratio to maintain the bioactivity of each component, individual quality control of each peptide before co-formulation, and validating the stability of the lyophilized mixture over time
They need to be confirmed in larger trials
Wegovy and Ozempic both contain semaglutide, but Wegovy provides a higher dose
Key Takeaways MT1 (afamelanotide) is FDA-approved (2019) and EMA-approved (2014) for erythropoietic protoporphyria under the brand name Scenesse
